Relationship Between Patient’s Risk Profile and Benefits in Mortality From Adjunctive Abciximab to Mechanical Revascularization for ST-Segment Elevation Myocardial Infarction: A Meta-Regression Analysis of Randomized Trials
- 18 January 2006
- journal article
- other
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 47 (3) , 685-686
- https://doi.org/10.1016/j.jacc.2005.11.018
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Abciximab as Adjunctive Therapy to Reperfusion in Acute ST-Segment Elevation Myocardial InfarctionJAMA, 2005
- Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial InfarctionCirculation, 2004
- Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantationThe American Journal of Cardiology, 2002
- Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarctionEuropean Heart Journal, 2002
- Advanced methods in meta‐analysis: multivariate approach and meta‐regressionStatistics in Medicine, 2002
- TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at PresentationCirculation, 2000